Physician profile
Debra Stein Clancy
NPI 1598877995
$705.26
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $45.59 · 2022: $92.04 · 2023: $262 · 2024: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $169.35 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $113.39 | 2019-2024 | Bexsero, Pediarix |
| Merck Sharp & Dohme LLC | $108.44 | 2019-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Pfizer INC. | $83.05 | 2019-2024 | |
| Tris Pharma INC | $73.67 | 2019-2024 | Dyanavel Xr |
| Sanofi Pasteur INC. | $61.63 | 2022-2023 | |
| Corium, LLC | $48.16 | 2023-2024 | Azstarys |
| Novartis Pharmaceuticals Corporation | $17.33 | 2019 | |
| Kyowa Kirin, INC. | $16.94 | 2023 | Crysvita |
| Rhodes Pharmaceuticals L.P. | $13.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Clancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.